Insmed (INSM) Preferred Dividend Payments (2011)
Insmed (INSM) posted quarterly Preferred Dividend Payments of -$9.2 million for Q1 2011.
Analysis
Insmed (INSM) Preferred Dividend Payments (2011) Analysis & Trends
Insmed's Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at -$9.2 million for Q1 2011.
- In Q1 2011, Preferred Dividend Payments changed N/A year-over-year to -$9.2 million; the TTM figure through Dec 2011 stood at -$9.2 million (changed N/A YoY), while the FY2011 annual figure was -$9.2 million, changed N/A from the prior year.
- Preferred Dividend Payments for Q1 2011 stood at -$9.2 million.
- The five-year high for Preferred Dividend Payments was -$9.2 million in Q1 2011, with the low at -$9.2 million in Q1 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |